Elevated first trimester serum uric acid as a predictor for the diagnosis of gestational diabetes mellitus by Parvathy, N
 1
 
 
A Dissertation on 
ELEVATED FIRST TRIMESTER SERUM URIC 
ACID AS A PREDICTOR FOR THE DIAGNOSIS OF 
GESTATIONAL DIABETES MELLITUS 
Dissertation submitted to 
THE TAMIL NADU Dr.M.G.R.MEDICAL UNIVERISTY 
CHENNAI. 
In partial fulfillment of the regulations 
for the Award of the degree of  
M.D., (Obstetrics & Gynaecology) 
Branch – II 
 
STANLEY MEDICAL COLLEGE 
CHENNAI. 
APRIL 2012 
 2
 
                               BONAFIDE CERTIFICATE 
     Certified that this dissertation is the bonafide work of  Dr. 
PARVATHY.N on  ELEVATED FIRST TRIMESTER SERUM URIC ACID AS A 
PREDICTOR FOR THE DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS 
during her M.D.,(Obstetrics & Gynaecology) course from April 2009 to 
April 2012 at the Stanley Medical College and Raja Sir Ramasamy Mudaliar 
Lying-in Hospital, Chennai. 
 
 
 
Prof.Dr.N.Hephzibah kirubamani,   Prof.Dr.D.Tamilselvi M.D., O.G., 
M.D., D.GO., MICOG., PhD,       
Professor & Head of the Department   Professor & Chief of the Department  
Dept. of Obstetrics & Gynaecology,   Dept. of Obstetrics & Gynaecology, 
       
Stanley Medical College &    Stanley Medical College &        
RSRM Lying In Hospital,         RSRM Lying In Hospital, 
Chennai – 600 013.     Chennai – 600 013.      
 
 
 
 
Prof. Dr.S.GEETHA LAKSHMI M.D.,Ph.D 
DEAN, 
Stanley Medical College  
Chennai – 600 001. 
 3
ACKNOWLEDGEMENT 
 At the outset, I would like to place on record my deep sense of gratitude to the 
Dean, Stanley Medical College and Prof.Dr.N.Hephzibah kirubamani, M.D., D.GO., 
MICOG., PhD, Professor and Head of the Department of Obstetrics & Gynaecology, 
RSRM lying in hospital, for allowing me to undertake this study on  ELEVATED 
FIRST TRIMESTER SERUM URIC ACID AS A PREDICTOR FOR THE 
DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS with much avidity.  
 In keeping with the maxim, “All is well that ends well”, I was able to carry out 
my study to my fullest satisfaction, thanks to guidance, encouragement, motivation and 
constant supervision extended to me, by my beloved Chief Prof. Dr.D.Tamilselvi, M.D., 
Professor and Chief of Unit V. Hence my profuse thanks are due for her.  
 I would be failing in my duty if I don’t place on record my sincere thanks to 
those patients who were the subjects of my study.  
I am bound by ties of gratitude to my respected Assistant Professors, in general, 
for placing, guiding and goading me on the right track from the very beginning of my 
career in Obstetrics and Gynaecology and till this day. 
I am fortunate to have my colleague PG’s of RSRM Lying hospital for their 
invaluable suggestions, relentless help for shouldering my responsibilities. Simply words 
cannot express its depth for their unseen contributions.  
           Lastly, my lovable thanks to my husband and my family for their moral support. 
 
 
 
 4
 
 
CONTENTS 
 
                   Page No. 
• INTRODUCTION           1 
• REVIEW OF LITERATURE          3 
• AIM OF THE STUDY              29 
• MATERIALS AND METHODS        31 
• RESULTS               34   
• DISCUSSION           46 
• CONCLUSION                                      51 
• BIBLIOGRAPHY          53 
• ANNEXURE 
¾ PROFORMA 
¾ MASTER CHART 
 
 
 
 5
  
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 6
 
 
 
INTRODUCTION 
 
                  Gestational diabetes mellitus is defined as carbohydrate 
intolerance of variable severity with onset or first recognition during present 
pregnancy. This definition applies whether or not insulin is used for 
treatment. Uric acid is associated with insulin resistance in non pregnant 
women. Outside of pregnancy, hyperuricemia is also associated with the 
markers of metabolic syndrome, including obesity and dyslipidemia.  
                            Uric acid is an independent risk factor for developing type 
2 diabetes mellitus within 10 years in non pregnant adults, an association 
that was stronger in women compared to men. 
                           Uric acid is the end product of purine metabolism catalyzed 
by enzyme xanthine oxidase/ dehydrogenase. In pregnancy uric acid is 
correlated with insulin resistance in women with gestational hypertension 
and higher at 24- 28 weeks of gestation in women diagnosed with GDM 
compared to women without diabetes. Uric acid is also higher in non 
pregnant women with a history of gestational diabetes, independent of body 
mass index. Since uric acid is associated with insulin resistance and predates 
development of type 2 diabetes in non pregnant adults, we hypothesis that 
higher uric acid in the first trimester would be associated with development 
of gestational diabetes.Compared with pre-pregnancy values uric acid 
concentrations decreased significantly by 8 weeks gestation and this reduced 
level  maintained until about 24 weeks. 
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REVIEW OF LITERATURE 
 
                Gestational diabetes mellitus is defined as carbohydrate 
intolerance of variable severity with onset or first recognition during present 
pregnancy. This definition applies whether or not insulin is used for 
treatment. 
  
 
A Short History of Gestational Diabetes as a Clinical Entity 
                       
              Gestational Diabetes as a clinical entity officially began in 1979 
when the National Diabetes Data Group (NDDG) issued an updated 
classification of diabetes types, including one that was present only during 
pregnancy.  In 1979, the First International Workshop-Conference on 
Gestational Diabetes Mellitus also met, essentially declared Gestational 
Diabetes a disease, finding it a significant health risk that needed treatment.  
Instead of the more neutral “Carbohydrate Intolerance of Pregnancy”, the 
term “Gestational Diabetes Mellitus” was used (often shortened in various 
resources to Gestational Diabetes, GD, or GDM).  Authorities felt that if the 
term ‘diabetes’ was used, women would be more likely to take the diagnosis 
seriously and insurance companies would be much more likely to cover 
treatment for it. 
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   However, the idea of sub clinical glucose levels in pregnancy affecting 
mother or baby (or being an early sign of future full-blown diabetes) had 
been discussed previously.   
Hadden et al (1998) reports incidents in the medical literature appearing as 
early as 1823 where diabetic-like conditions presented during pregnancy but 
seemed to disappear afterwards.  However, greater attention to the concept 
that lesser degrees of hyperglycemia might negatively affect a pregnancy 
began to appear in the 1940s and 1950s.  In these studies, researchers found 
increased perinatal mortality among the babies of women who developed 
diabetes years later, leading to the coining of the term “prediabetes in 
pregnancy.” 
Belgian researcher J.P. Hoet et al published a study on “Carbohydrate 
Metabolism During Pregnancy” and first used the term, “metagestational 
diabetes” in 1954.  His investigations sparked a series of investigations in 
the 50s and 60s.    
Jorgen Pedersen et al probably was the first to use the modern term 
“gestational diabetes” in 1967, and this was the term promoted by Dr. 
Norbert Freinkel and associates, later adopted by the First International 
Workshop-Conference on Gestational Diabetes Mellitus.  
The first major prospective study was established in Boston in 1954, and the 
1-hour 50-gram glucose screening test was first used there. 
 The results from this Boston study were presented by O’Sullivan and 
Mahan et al in 1964, and showed that higher blood glucose values in 
pregnancy correlated with the development of diabetes later in life. 
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In October 1979, Dr. Norbert Freinkel et al (representing the American 
Diabetes Association) and Dr. John Josimovich et al (representing the 
American College of Obstetricians and Gynecologists) met in Chicago at the 
First International Workshop Conference on Gestational Diabetes Mellitus.  
They gathered together experts from around the world to share their clinical 
experience, research, and opinions about GDM.  Between this conference 
and the re-classifications from the National Diabetes Data Group, 
Gestational Diabetes as an official clinical entity was born.  It is now defined 
as, “Carbohydrate intolerance of variable severity with onset or first 
recognition during the present pregnancy.  The definition applies 
whether insulin is used for treatment or the condition persists after 
pregnancy but does not exclude the possibility that the glucose 
intolerance may have antedated the pregnancy.” 
 
PREVALENCE OF GDM 
                           Globally, the quoted prevalence of GDM ranges from  1 - 
16% (Agarwal, Dhatt, Punnose & Koster, 2005). This may be in part due to 
the different screening and diagnostic strategies employed to identify the 
condition and the particular population studied. The Australian Carbohydrate 
Intolerance Study (ACHOIS) undertaken in 14 centers in Australia and 4 
centres in the United Kingdom reported that GDM affected 2 - 9% of all 
pregnancies (Crowther et al, Hiller et al, Moss et al, McPhee et al, Jeffries & 
Robinson et al, 2005). Whilst, Tuffnell et al, West et al and Walkinshaw et 
al (2003) in their systematic review of  treatments for GDM and impaired 
glucose tolerance (IGT), for the 7 Cochrane Database state that 3-6% of all 
pregnancies are affected by GDM and IGT.  
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Terminology in the literature, relating to disturbances of carbohydrate 
metabolism in pregnancy can be confusing. In 1985, the World Health 
Organization (WHO) classification subdivided abnormal glucose tolerance 
in pregnancy into three categories defined by fasting venous glucose levels 
and venous plasma glucose values two hours after a 75gram oral glucose 
load (Nordin et al, Wei et al, Naing et al and Symonds et al, 2006). The three 
classifications were impaired fasting glucose (IFG), impaired glucose 
tolerance (IGT) and GDM. The revised WHO classification (1999) now 
defines GDM as any abnormal carbohydrate metabolism first recognized, or 
diagnosed in pregnancy, regardless of severity. Remnants of the earlier 
classification are still encountered in the literature. 
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PATHOGENESIS 
 
 
Pregnancy is a condition of  
1) Accelerated starvation  
2) Facilitated anabolism 
3) Hyperinsulinism 
4) Insulin resistance. 
 
1.Accelerated starvation        
There is fasting hypoglycemia because 
• Glucose is diverted to fetus by facilitated diffusion. 
• Increase insulin secretion during pregnancy.  
• Amino acid acids diverted to fetus by active transport leading to      
           substrate deficiency  syndrome in the mother. 
• Mother uses fat as a fuel resulting in ketogenesis 
2. Facilitated Anabolism  
Prolonged hyperglycemia after eating because of  
• Increase absorption from gut  
• Delayed glucose exchange from blood. 
• Decrease uptake by muscles and splanchnic tissues. 
• Decrease conversion to glycogen in liver. 
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3. Hyperinsulinism 
  Increase in estrogen and progesterone leads to 
• β cell hyperplasia there by leading to increase insulin secretion. 
• Increase sensitivity of β cells to glucose load. 
• Increase suppression of glucose after meals. 
                        
  4. Insulin Resistance 
• Hormones         
              HPL and prolactin 
• Android obesity  
             Increase omental and mesenteric fat. 
• αTNF  
              Impaired insulin signaling  
              Inhibits insulin receptors tyrosine kinase activity. 
              At the molecular level,there is decrease GLUT 4 protein transporter. 
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NDDG CLASSIFICATION 
 
 
 New name Old name 
Type I IDDM Juvenile Diabetes 
Type II NIDDM Adult onset 
Type III  Gestational Diabetes 
 
 
 
 
 
AMERICAN COLLEGE OF OBSTETRICS &GYNAECOLOGY 
 
 
     Class 
 
    Onset 
 
Fasting 
glucose 
 
2 hours post 
prandial 
glucose 
 
Therapy 
A1 Gestational <105mg/dl <120mg/dl Diet 
A2 Gestational >105mg/dl >120mg/dl Insulin 
Class B – H similar to White’s classification 
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WHITE’S CLASSIFICATION OF DIABETES DURING 
PREGNANCY 
 
Gestational diabetes 
           Discovered during pregnancy, 
glycemia may or may not be 
maintained by diet alone and insulin 
may be required 
Class A 
Discovered before pregnancy 
,controlled with diet alone ,any 
duration or age of onset  
Class B 
Onset age 20 years or older, duration 
less than 10 years 
Class C 
Onset age 10 -19 years, duration 10 -
19 years. 
Class D 
Onset age under 10 years duration 
over 20 years, background 
retinopathy. 
Class R 
Proliferative retinopathy or vitreous 
hemorrhage. 
Class F 
Nephropathy with proteinuria over 
500mg/day 
Class RF 
Criteria for both class R and F 
coexist 
Class H 
Atherosclerotic heart disease 
clinically evident 
Class T Prior renal transplantation 
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Risk assessment and timing of screening for Gestational 
Diabetes: 
 
LOW RISK- 
All of the following:  
• Members of an ethnic group with a low prevalence of GDM. 
• No known diabetes in first degree relatives. 
• Age <25 years 
• Weight normal before pregnancy 
• Weight normal at birth. 
• No history of abnormal glucose metabolism. 
 
These patients blood glucose screening not routinely required. 
 
AVERAGE RISK 
One or more of the following: 
• Member of an ethnic group with a high prevalence of GDM. 
• Diabetes in a first degree relative. 
• Age ≥25 years. 
• Over weight before pregnancy. 
• Weight high at birth. 
  
  These patients require blood glucose testing at 24-28 weeks (one or two   
  Procedure). 
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HIGH RISK 
• Marked obesity 
• Strong family history of Type II DM. 
• Previous history of GDM, impaired glucose metabolism or glucosuria. 
 
These patients should perform glucose testing as soon as feasible. 
 
 
 
 
 
 
 
HIGH RISK GESTATIONAL DIABETES 
History of neonatal death 
History of fetal macrosomia 
Concomitant obesity and/or hypertension. 
Development of oligohydramnios ,polyhydramnios,preeclampsia,or fetal 
macrosomia 
Inadequate metabolic control with diet alone. 
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                                            SCREENING TESTS  
 
                    Surest screening procedure is estimation of blood glucose. 
O’Sullivan and Mahan glucose challenge test is the preferred test. Plasma 
glucose is measured 1 hour after 50 grams of oral glucose load without 
regard to the time of last meal. Plasma glucose >140 mg% - go for 3 hour 
100 gram oral GTT. 
 
Seshiah’s spot test 
Plasma glucose estimation is done in relation to the last meal.  
Critical values -      
             0 hour -85 mg% 
             ½ hour -95 mg% 
              1 hour -105 mg% 
              2 hour -105 mg% 
              2 hour   30 mts-95 mg% 
              3 hour -90 mg% 
 
SOURCE OF SPECIMEN 
• Plasma   glucose    is     14%   higher than whole blood glucose   level. 
• Capillary blood glucose level is 20 mg% higher than whole blood 
level. 
• Urine sugar on freshly voided urine alone with blood sugar gives 
some idea on renal threshold. 
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OTHER SCREENING TESTS 
 
1) Glycosuria –glycosuria on the second fasting urine is significant. Also 
glycosuria if associated with ketonuria is significant. Normally 100 mg of 
glucose is excreted per day.If exceeded, can be measured by 
                   Benedict’s  test. 
                   Clinstix test. 
 
Benedict’s test is positive with all reducing sugars and with some drugs, so it 
is non specific. 
Clinistix test is specific for glucose. 
PIT FALLS- 
• Blood sugar does not correlate with urine sugar always. 
• Differs from person to person and on various occasions. 
• Glycosuria is present in  
               Diabetes mellitus  
               Alimentary glycosuria  
               Renal glycosuria 
               Lactosuria 
 
2) Instant blood glucose methods using strips and meters  
           Easy to perform 
           Venepunture not needed. 
           Quick results. 
           But lack precision 
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3) Glycosylated Hb (HbA1C)- Reflects glycemic control over last 2-3 
months.  
Normal range --- 5- 8%. 
<8.5 %   ---- good control. 
8.5- 9.5%----fair   control. 
>9.5%    ----poor control. 
Variable values in renal failure. 
Reduced in anaemia ,haemoglobinopathies and blood transfusion. 
Costly test. 
 
 
HbA1C in Ist Trimester 
 
HbA1C in Ist trimester Congenital anomalies Abortions 
<9.3 % 3%                12.4% 
≥14.4% 4% 37.5% 
 
 
 
4) Serum fructosamine assay. 
    Reflects glycemic control over last 2 weeks. 
    Normal value upto 285 µmol/L. 
    Reliable in anaemia & others. 
    Costly test.   
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GOLD STANDARD TEST  
Gold standard test is the 3 hours 100grams oral glucose tolerance test. 
Preparation of the patient. 
• Unrestricted diet in the previous 3 days. 
• Over night fasting of   8 -10 hours. 
• Testing in the morning. 
• Should be ambulant. 
• Smoking should be avoided. 
• Stop drugs – Phenytoin , Thiazides, OC pills, Steriods. 
• Postpone after 3 weeks if major surgery/ stress. 
 
 
 
PROCEDURE 
After overnight fasting, fasting blood sugar is collected along with 
urine sugar.100grams of glucose is given. It can be dissolved in 200 ml of 
plain water or lime water to improve palatability. Venous blood is drawn for 
3 hours along with urine. 
 
 
 
 
 
 
 
 
 22
DIAGNOSTIC CRITERIA 
 
SPECIAL TESTS 
Intravenous Glucose tolerance test (GTT) 
25 grams glucose in 50%solution is given IV over 3 minutes. Blood sample 
is collected every 10 minutes for 1 hour. 
Graph of blood glucose against time plotted. 
K (Constant)=0.693 x 100/t½. 
t½ - Time taken for blood glucose to fall to 50%of the value at 10 minutes.  
Normal –K=1.2 TO 2.3.<1.2- Diagnosed as GDM. 
Advantages 
Short duration 
Useful in patients with Malabsorption syndromes. 
Disadvantages 
Frequent collection  
Non physiological so only for research purposes 
 O’Sullivan 
&Mahan (whole 
blood) mg/dl. 
NDDG 
(Plasma)mg/dl 
Carpenter 
&Coustan 
(Plasma) 
mg/dl 
Sacks 
(Plasma) 
Fasting 90 105 95 96 
1Hour 165 190 180 172 
2Hour 145 165 155 152 
3 Hour 125 145 145 131 
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INVESTIGATIONS 
 
FOR CONFIRMATION – GTT 
ROUTINE ANTENATAL INVESTIGATIONS  
     1. Urine for protein, sugar, and microscopic examination. 
     2. Hb 
     3. VDRL,HIV,HBsAg  
     4. Blood for grouping and Rh typing. 
 
INVESTIGATIONS FOR ASSESSING GLYCEMIC STATUS. 
INVESTIGATIONS FOR ASSESSING COMPLICATIONS 
 
 
INVESTIGATION FOR ASSESSING GLYCEMIC STATUS: 
• Urine sugar monitoring – unreliable. 
• Blood sugar estimation is best. 
In controlled GDM, DM, once in 2-4 weeks. 
Self monitoring of blood glucose (SMBG) is mandatory in  
• All the pregnant women on insulin. 
• Patients with fluctuating glucose levels. 
• Patients showing recurrent ketosis or hypoglycemia. 
• In the perioperative period. 
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INVESTIGATIONS FOR ASSESSING COMPLICATIONS: 
Infections 
• Asymptomatic bacteriuria to be looked for at booking, 28, 32, 36 
weeks. 
• Vulval moniliasis screening 
• Urine should be examined for proteins and microscopic deposits 
during each visit. 
 
Diabetic nephropathy  
• Urine for proteins using dipstick during each visits. 
• If dipstick +ve 24 hours urinary protein for microalbuminuria. 
• Renal function tests- blood urea, serum creatinine, serum electrolytes. 
 
Diabetic retinopathy  
• Measuring visual acuity  
• Opthalmoscopic examination through dilated pupils 
Stages  
1. Non proliferative retinopaty. 
2. Preproliferative retinopathy. 
3. Proliferative retinopathy. 
• Cononary heart disease and cardiomyopathy. ECG in all the leads and 
echocardiogram. 
• Fasting lipid profile. 
• Urine for ketone bodies and serum electrolytes in the presence of high 
blood sugar, persistent vomiting and infection 
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Screening for fetal anomalies: 
• Glycosylated Hb estimation. 
• Chorionic villous sampling. 
• Maternal serum α fetoprotein estimation. 
• Amniocentesis. 
• Targeted ultrasound. 
• Fetal echocardiogram 
 
 
 
Ultrasound 
Assessment of altered growth 
Ultrasound every 4weeks from 20 weeks. 
MACROSOMIA can be identified by 
• AC and thigh diameter >90th percentile. 
• Head and femur measurements < 90th percentile. 
• Abdominal girth >head circumference. 
• AC change >1-2 cm/week. 
• Increase subcutaneous fat. 
For assessing amniotic fluid volume. 
For assessing placental position. 
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URIC ACID 
           Uric acid is the end product of purine metabolism. Purines are 
obtained from both dietary sources and from the breakdown of body 
proteins. Organ meats such as liver, kidneys, and sweetbreads, sardines, 
anchovies, lentils, mushrooms, spinach, and asparagus are all rich sources of 
purines. The kidneys excrete uric acid as a waste product. The kidneys 
excrete two-thirds of the uric acid produced daily; the remaining one-third is 
excreted in the stool.  
           The exact level of uric acid that is considered pathological is 
controversial. In recent years, it has been recognized that the normal ranges 
of uric acid are quite wide. Because of this wide range, and because uric acid 
levels show day-to-day and seasonal variations in the same person, several 
uric acids levels may be ordered over a period of time. Urine uric acid levels 
may also be used to evaluate gout or determine oversecretion of uric acid.  
Reference values: Serum Uric Acid  
• Adult males: 2.0 - 7.5 mg/dl  
• Adult females: 2.0 - 6.5 mg/dl; in early pregnancy uric acid levels 
fall by about one-third but rise to non-pregnant levels by term  
• Children (ages 10-18)  
o Males: 3.6 - 5.5 mg/dl; significant rise in males at ages 12-14 
coincides with puberty.  
o Females: 3.6 - 4 mg/dl  
• Elderly:  
o Males older than 40: 2 - 8.5 mg/dl  
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      Females older than 40: 2 - 8.0 mg/dl; rise in women related to 
menopause  
The normal range for urinary uric acid is between 250 - 750 mg over a 24-
hour period. Uric acid levels tend to vary day to day. It is also important to 
check the laboratory reference values for each work setting.  
An elevated blood uric acid level, also known as hyperuricemia, is seen in:  
• Gout  
• Renal disease and renal failure  
• Alcoholism  
• Dehydration  
• Leukemia and lymphoma  
• Starvation  
• Metabolic acidosis  
• Toxemia of pregnancy  
• Infectious mononucleosis  
• Hyperlipidemia  
• Hemolytic anemia  
• Excessive cell destruction associated with chemotherapy and radiation 
treatment  
An overproduction of uric acid occurs when there is excessive cell 
breakdown and catabolism of nucleonic acids such as seen in gout, excessive 
production and destruction of cells, as may occur in leukemia or during 
cancer therapy, or problems with uric acid excretion due to renal failure.  
 28
Changes in serum uric acid concentrations during normal 
pregnancy: 
                         Serial changes in serum uric acid concentrations have been 
studied in a group of healthy women before conception, at regular intervals 
throughout pregnancy and finally 12 weeks after delivery. Compared with 
pre-pregnancy values uric acid concentrations decreased significantly by 8 
weeks gestation and this reduced level was maintained until about 24 weeks. 
Thereafter the concentrations increased such that by term they were greater 
than the pre-pregnancy values in the majority of patients and remained 
elevated until at least 12 weeks after delivery. If clinical management during 
the second half of pregnancy is to be based on increases in serum uric acid 
concentrations then such increases will have to be carefully interpreted 
against the background of rising concentrations which occur as part of the 
physiological response to normal pregnancy. 
 
CHANGES IN NORMAL PREGNANCY 
 Normal values of serum uric acid 
(mg/dl) 
 
Non pregnant adult 2.5 – 5.6 
First trimester 2.0 – 4.2 
Second trimester 2.4 – 4.9 
Third trimester 3.1 – 6.3 
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ASSOCIATION OF SERUM URIC ACID AND GDM: 
                               It is possible that the association of uric acid with insulin 
resistance is causal. Two mechanisms have been hypothesized by which 
uric acid can cause insulin resistance. Nakagawa et al. proposed that uric 
acid causes endothelial dysfunction and decreases nitric oxide production by 
the endothelial cell. In animals, insulin's action on glucose uptake into cells 
in the skeletal muscle and adipose tissue is dependent on nitric oxide. Thus 
decrease in nitric oxide lead to decreased glucose uptake and the 
development of insulin resistance.  
                             Another mechanism by which uric acid may induce insulin 
resistance may be that uric acid causes inflammation and oxidative stress in 
adipocytes, which is a contributor to the development of metabolic 
syndrome in mice.  
 
First trimester hyperuricemia was associated with an increased risk of 
developing gestational diabetes mellitus. The risk of developing gestational 
diabetes was 3.25 fold higher if first trimester uric acid was in 4 th quartile. 
Although uric acid was strongly associated with body mass index, the risk of 
gestational diabetes was increased among women with elevated first 
trimester   uric acid independent of BMI. Uric acid increases with increased 
protein intake, alcohol consumption, decreased excretion, or increased 
endogenous production. 
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            Uric acid in the first trimester likely approximates pre-conception 
uric acid, and elevated uric acid may identify women who are predisposed to 
metabolic syndrome with an increased risk of developing GDM, 
independent of obesity. Alternatively, uric acid decreases early in 
pregnancy, so perhaps women with elevated uric acid have a poor adaptation 
to pregnancy (i.e. abnormal placentation), putting them at risk for adverse 
pregnancy outcomes such as GDM. 
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            Many studies on the association between uric and GDM have 
been performed. 
Zekai Tahir Burak  et al  studied  Relationship between serum uric acid, 
creatinine, albumin and gestational diabetes mellitus at The Women's Health 
and Research Hospital, Ankara, Turkey, and found  
Creatinine levels were significantly higher in the diabetic group than in the 
control group [0.6+/-0.15 vs. 0.43+/-0.1 mg/dL (53.04+/-13.26 micromol/L 
vs. 38.01+/-8.84 micromol/L), p<0.001]. Uric acid levels were also higher in 
the diabetic patients, this elevation was statistically significant [4.42+/-1.09 
vs. 3.1+/-0.84 mg/dL (260.78+/-64.31 micromol/L vs. 231.49+/-49.56 
micromol/L), p<0.001]. There were no differences in mean albumin 
concentrations or liver function tests. 
 
Title:  Hypertension in pregnancy: official journal of the International 
Society for the Study of Hypertension in Pregnancy Volume: - ISSN:  1525-
6065 ISO Abbreviation:-Publication Date:  2010 Sep studied that High Uric 
Acid Level during the First 20 Weeks of Pregnancy is Associated with 
Higher Risk for Gestational Diabetes Mellitus and Mild Preeclampsia. 
 
Results: Significant linear association was documented between UA level in 
the first 20 weeks and the prevalence of GDM and mild preeclampsia. The 
lowest and the highest prevalence of GDM were found in the UA </= 2.4 
mEq/L group (6.3%) and in the UA > 5.5 mEq/L group (10.5%) (p < 0.001), 
respectively.  
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Samer  Samir Lamey   et al , in Heliopolis Hospital  under supervision by 
Prof. Dr.Ali Farid Mohamed Ali Professor of Obstetrics & Gynecology 
Faculty of Medicine Ain Shams University,2010 studied the Risk of elevated 
body mass index in expectation the presence of gestational diabetes mellitus 
and associated elevated uric acid concentrations 
Lind T, Godfrey KA, et al studied the Changes in serum uric acid 
concentrations during normal pregnancy. He found that compared with pre-
pregnancy values uric acid concentrations decreased significantly by 8 
weeks gestation and this reduced level was maintained until about 24 weeks. 
Thereafter the concentrations increased such that by term they were greater 
than the pre-pregnancy values in the majority of patients and remained 
elevated until at least 12 weeks after delivery. 
Simmi Kharb et al  studied  the relation between  Ascorbic acid and uric 
acid levels in gestational diabetes mellitus and found that  Significantly low 
vitamin C levels were observed in GDM as compared to those in controls 
(P<0.05). Significantly high serum uric acid levels were observed in GDM 
as compared to those in controls (P<0.05).Vitamin C and uric acid levels 
showed a significant negative correlation (r = 0.25, P<0.05).  
 
      Control group         Study group 
Vit C 1.077±0.392 0.801±0.119 
Uric acid 3.73±0.14 5.23±0.33 
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AIM OF THE STUDY 
 
The aim of the study is to test the hypothesis that elevated uric acid 
measured in the first trimester of pregnancy are associated with the 
subsequent development of gestational diabetes mellitus. 
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MATERIALS AND METHODS 
 
This is a prospective study conducted in Government RSRM-lying 
in hospital attached to Stanley Medical College Chennai during October 
2010 – November 2011.A total of 154 antenatal women belonging to first 
trimester were included in the study. The aim of the study was explained to 
the antenatal women and informed consent obtained. 
 
INCLUSION CRITERIA - 
            
           Antenatal women with gestational age < 15 weeks. 
 
EXCLUSION CRITERIA –  
Pregestational diabetes mellitus 
Renal disease 
Liver disease 
Cardiovascular disease 
Gout 
  Smoking 
Detailed history obtained from the patients. General examination was done.  
Per abdomen examination was done. Ultrasound was done to calculate the  
gestational age. 
 
MEASUREMENT OF PLASMA URIC ACID: 
 
Venous blood sample was withdrawn from antenatal women with 
gestational age <15 weeks. The samples were centrifuged to separate the 
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serum and stored at -70ºC till examined. Uric acid measured using 
colorimetric assay with detection limit of 10 mg/dl. The coefficient was 0.9%. 
SCREENING FOR GDM  
 
All antenatal mothers were followed up around 24-28 weeks for 
routine GDM screening with 50 grams of oral glucose challenge test 
(GCT).Those antenatal mothers with plasma glucose level after 1 hour ≥140 
mg/dl, these women are considered high risk and are subjected to oral glucose 
tolerance test (OGTT). 
 
ORAL GLUCOSE TOLERANCE TEST 
 
After about 8 hours of fasting, those antenatal women with positive 
GCT (≥140mg/dl) are subjected to GTT. Fasting blood glucose is taken. After 
which 100 grams of glucose is taken oral. 1hr, 2hr, 3hr glucose levels are 
measured. Patients are considered to have GDM if two or more of the 4 values 
exceed the following:  
Fifth international workshop conference on gestational diabetes- 
               
                 Fasting     -       95 mg/dl 
                    
                 1hr           -        180 mg/dl  
    
                 2hr           -         155 mg/dl 
 
                 3hr           -         140 mg/dl 
 
 
Those antenatal women with positive GTT were admitted as in-patient 
and further evaluated. These antenatal women were managed with diet and 
some with both insulin and diet. 
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DISTRIBUTION OF SERUM URIC ACID 
 
 
 
 
Serum Uric Acid
ElevatedNormal
Fr
eq
ue
nc
y
100
80
60
40
20
0
 
 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Normal 94 61.0 61.0 61.0 
 Elevated 60 39.0 39.0 100.0 
 Total 154 100.0 100.0  
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This table shows the distribution of serum uric acid among the total 
antenatal patients. 94 patients had normal uric acid constituting about 61% 
and 60 patients had elevated uric acid constituting about 39%. 
RELATIONSHIP BETWEEN SERUM URIC ACID AND GCT 
 
            
GCT
PositiveNormal
Fr
eq
ue
nc
y
100
80
60
40
20
0
 
 
 
 
Frequency Percent Valid Percent Cumulative Percent 
Valid Normal 89 57.8 57.8 57.8 
 Positive 65 42.2 42.2 100.0 
 Total 154 100.0 100.0  
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This above table shows the relationship between serum uric acid and GCT. 
GCT was normal in 89 patients, constituting 57.8% and GCT was positive in  
65patients constituting 42.2% 
 
GLUCOSE TOLERANCE TEST 
 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Positive 
13 6.4 6.4 6.4 
Negative 
141 91.5 91.5 100.0 
Total 
154 100.0 100.0  
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This above table infers that 13 patients had GTT constituting 6.4% 
and 141 patients negative constituting 91.5%.  
 
 
Serum Uric Acid * GCT Cross tabulation 
 
 
 
    
GCT 
Total Normal Positive
Serum Uric 
Acid 
Normal Count 69 25 94 
% within 
Serum Uric 
Acid 
73.4% 26.6% 100.0% 
% within 
GCT 77.5% 38.5% 61.0% 
Elevated Count 20 40 60 
    % within 
Serum Uric 
Acid 
33.3% 66.7% 100.0% 
% within 
GCT 22.5% 61.5% 39.0% 
Total  Count 89 65 154 
% within 
Serum Uric 
Acid 
57.8% 42.2% 100.0% 
% within 
GCT 100.0% 100.0% 100.0% 
 
 
  
In our study of the total patients (60) with elevated uric acid,20 patients had 
normal GCT – constituting 22.5%.And the remaining 40 patients with 
elevated uric acid had positive GCT constituting 61.5%.(>140 mg/dl). 
And among those with normal uric acid total (94), 69 patients had normal 
GCT constituting  77.5% and 25 patients was positive for GCT with 38.5%.  
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RELATION BETWEEN SERUM URIC ACID AND GCT 
Serum Uric Acid
ElevatedNormal
Fr
eq
ue
nc
y
80
70
60
50
40
30
20
10
GCT
Normal
Positive
  
Chi-Square Tests 
 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) P value
Pearson Chi-
Square 
24.108(
b) 1 .000   
<0.001 
 
 
 
 
Continuity 
Correction(a) 22.493 1 .000   
Likelihood 
Ratio 24.463 1 .000   
Fisher's Exact 
Test    .000 .000 
Linear-by-
Linear 
Association 
23.951 1 .000   
N of Valid 
Cases 154     
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum 
expected count is 25.32. 
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Serum Uric Acid * GTT Crosstabulation 
 
    
GTT 
Total 
Positiv
e 
Negativ
e 
Serum Uric 
Acid 
Elevated Count 10 50 60 
% within 
Serum Uric 
Acid 
16.7% 83.3% 100.0% 
% within 
GTT 76.9% 35.5% 39.0% 
Normal Count 3 91 94 
% within 
Serum Uric 
Acid 
3.2% 96.8% 100.0% 
% within 
GTT 23.1% 64.5% 61.0% 
Total Count 13 141 154 
% within 
Serum Uric 
Acid 
8.4% 91.6% 100.0% 
% within 
GTT 100.0% 100.0% 100.0% 
 
 
 
 
 
In our study among the 60 patients with elevated uric acid ,10 patients were 
positive for GTT . And the remaining 40 were negative for GTT. 
And among the  94 patients with normal uric acid only 3 were GTT positive. 
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RELATIONSHIP BETWEEN SERUM URIC ACID AND GTT 
Serum Uric Acid
NormalElevated
Fr
eq
ue
nc
y
100
80
60
40
20
0
GTT
Positive
Negative
 
                                                    CHISQUARE TESTS 
 
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum 
expected count is 5.06. 
  Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 
8.604(
b) 1 .003  
Continuity 
Correction(a) 6.949 1 .008  
Likelihood 
Ratio 8.504 1 .004  
Fisher's Exact 
Test  .006 .004 
Linear-by-
Linear 
Association 
8.548 1 .003  
N of Valid 
Cases 154  
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In our study, maternal age had no much correlation with the serum uric acid. 
In our study age between 21 – 25 years had much frequency constituting 
55.8%. 
 
    
 MATERNAL AGE (YEARS) 
 
Age Group in years
Above 3026-3021-25Upto 20
Fr
eq
ue
nc
y
100
80
60
40
20
0
 
In a study by S. Katherine LAUGHON  et al, The mean maternal age and 
gestational age at sampling decreased slightly with increasing uric acid 
quartile. 
 Frequency Percent 
Valid 
Percent Cumulative Percent
Valid Upto 20 18 11.7 11.7 11.7
  21-25 86 55.8 55.8 67.5
  26-30 44 28.6 28.6 96.1
  Above 
30 6 3.9 3.9 100.0
  Total 154 100.0 100.0  
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Gestational age in weeks 
 
                        
 
In our study the frequency is high around 10.1 – 11 weeks.   
 
And this had no much correlation within the first trimester. 
 
 
 
Gestational age in weeks
Above 11
10.1-11
9.1-10
Below 9
 
 
 
 
    Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Below 9 43 27.9 27.9 27.9
9.1-10 39 25.3 25.3 53.2
10.1-11 57 37.0 37.0 90.3
Above 11 15 9.7 9.7 100.0
Total 154 100.0 100.0  
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Reliability of the test in predicting GDM 
 
Sensitivity specificity Positive 
likelihood 
ratio 
Negative 
likelihood 
ratio 
Diagnostic 
odds ratio 
76.9 64.5 2.678 0.383 6.991 
 
Risk estimate 
 Value 
95% 
Confidence 
Interval 
Lower Upper 
Odds Ratio for 
Serum Uric Acid 
(Elevated / 
Normal) 
6.067 1.596 23.066 
For cohort GTT = 
Positive 5.222 1.498 18.207 
For cohort GTT = 
Negative .861 .764 .970 
N of Valid Cases 154  
 
                 In a similar study by S. Katherine LAUGHON et al, his 
hypothesis was the mean maternal age and gestational age at sampling 
decreased slightly with increasing uric acid quartile. Maternal pre-pregnancy 
BMI increased linearly with increasing uric acid quartile (p<0.01 for trend) 
and was associated with uric acid with an r2 of 0.16 (p<0.001). 
Of the 73 women who developed gestational diabetes mellitus, 34 (46.6%) 
had uric acid in the 4th quartile and 39 (53.4%) had a BMI <30 kg/m2. 
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Risk of gestational diabetes by first trimester uric acid quartile 
 
. 
 
 
 
 
 
 
 
First trimester uric acid concentrations ≥3.6 mg/dl, (the highest quartile) 
were associated with a trend towards increased risk of developing 
gestational diabetes (adjusted OR=3.91; 95%CI: 0.75, 1.96) compared to 
women with concentrations below this concentration (lower three quartiles), 
after adjusting for BMI. Using a cut point of 3.6 mg/dl yielded a positive 
predictive value (PPV) of 12.0% and negative predictive value (NPV) of 
96.7% for development of GDM. The area under the receiver operator curve 
was 0.7. 
                                          
COMPARISION 
 
 OUR STUDY S. KATHERINE 
LAUGHON et al 
Positive predictive 
value 
16.7 12 
Negative predictive 
value 
96.8 96.7 
Odds ratio 5.2 3.9 
 
GDM 
n (%) Adjusted OR* (95% CI) 
1st (2.1) 7 (0.5) ref 
2nd (2.7) 12 (0.8) 1.62 (0.63-4.22) 
3rd (3.2) 20 (1.3) 2.35 (0.96-5.78) 
4th (4.2) 34 (2.2) 3.95 (1.35-7.83) 
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DISSCUSSION 
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DISSCUSSION 
 
 
 
                  Pregnancy induces progressive changes in maternal carbohydrate 
metabolism. As pregnancy advances insulin resistance and diabetogenic 
stress due to placental hormones necessitate compensatory increase in 
insulin secretion. When this compensation is inadequate gestational diabetes 
develops 
                        
                    It is possible that the association of uric acid with insulin 
resistance is causal. Two mechanisms have been hypothesized by which uric 
acid can cause insulin resistance. Nakagawa et al. proposed that uric acid 
causes endothelial dysfunction and decreases nitric oxide production by the 
endothelial cell. In animals, insulin's action on glucose uptake into cells in 
the skeletal muscle and adipose tissue is dependent on nitric oxide. Thus, 
decreases in nitric oxide lead to decreased glucose uptake and the 
development of insulin resistance. Another mechanism by which uric acid 
may induce insulin resistance may be that uric acid causes inflammation and 
oxidative stress in adipocytes, which is a contributor to the development of 
metabolic syndrome in mice. 
 
                      In our prospective study 154 antenatal women were included 
belonging to first trimester, who were attendees of Govt. RSRM Lying-in 
Hospital attached to Stanley medical college, during Dec 2010 to Nov2011. 
In our study of the total mothers who developed GDM 10 Antenatal mothers 
had elevated serum uric acid in first trimester, which  constitute about  16.7( 
% within in GTT).And among 3 GDM mothers  with normal serum uric acid  
constitute about 3(% within GTT).with p value <0.001) 
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In our study all antenatal women undertook glucose challenge test (GCT), 
more of a screening test. Of the normal uric acid GCT was positive among 
25 mothers(constituting 26.6%).Of the elevated serum uric acid GCT was 
positive among 40 mothers(constituting 66.7%).With significant p< 0.001 
 
                The risk of developing gestational diabetes was 3.25-fold higher if 
first trimester uric acid was in the 4th quartile. Although uric acid was 
strongly associated with body mass index, the risk of gestational diabetes 
was increased among women with elevated first trimester uric acid 
independent of BMI. 
 
                 Our findings are consistent with the association of uric acid with 
insulin resistance in the non-pregnant population.1 In a large cross-sectional 
study of 53,477 non-pregnant adults, serum uric acid was positively 
correlated with fasting serum glucose and insulin resistance, as well as 
features of the metabolic syndrome, including waist circumference, low 
HDL cholesterol, hypertriglyceridemia, hypertension and fasting glucose ≥ 
110 mg/dl. 
 
                  A study by Di Cianni et al. in which serum uric acid was 
measured at a median of 16 months postpartum in women who had 
pregnancies complicated by gestational diabetes. Uric acid was significantly 
higher in women with metabolic syndrome (4.8 ± 1.2 mg/dl) versus women 
without metabolic syndrome (4.1 ± 0.8, p<0.01), independent of BMI, and 
metabolic syndrome is a known risk factor for developing type 2 diabetes. 
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                  We did not measure creatinine in order to adjust for glomerular 
filtration rate (GFR), but the majority of women would be expected to have 
normal excretion since we excluded women with prior diabetes, 
hypertension, kidney disease or major medical problems 
 
                Hyperuricemia has also been demonstrated to be a risk factor for 
developing type 2 diabetes. In our study, we found that uric acid ≥ 4.2 mg/dl 
early in pregnancy is associated with a 3-fold increased risk of developing 
gestational diabetes. 
 
                This study demonstrates a striking association between first 
trimester uric acid and risk of developing gestational diabetes, only half of 
the women with uric acid in the highest quartile actually developed the 
disease. This finding may be due to different pathways of development of 
gestational diabetes. Women who have a pregnancy complicated by 
gestational diabetes have up to a 50% chance of developing type 2  diabetes 
in their lifetime. It would be interesting to know whether these were the 
women with elevated uric acid in the first trimester. 
 
               The relationship of uric acid elevation in early pregnancy does 
indicate that metabolic state may affect adverse pregnancy outcomes. With 
the increase in both metabolic syndrome and obesity, more women are 
entering pregnancy with these conditions. It is possible that of the women 
who develop GDM, those with elevated first trimester uric acid are the 
women who are at risk to develop type 2 diabetes, and this warrants future 
investigation. 
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Thus we postulate that elevated  first trimester serum uric acid helps 
in the prediction of gestational diabetes mellitus  and also  identification 
those at risk of developing type II Diabetes mellitus of follow up; also to 
counsel the patient about the short term and long term outcomes. 
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CONCLUSION 
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CONCLUSION 
 
                   The objective of implementing an antenatal screening test for 
GDM is to identify pre-symptomatic women who will subsequently develop 
complications of pregnancy and implement efficacious treatment to reduce 
morbidity and mortality. Currently, complications of pregnancy due to GDM 
are not diagnosed until mid-late gestation. 
                   It is important to recognize that by the time GDM is diagnosed 
in the late second or early third trimester of pregnancy, the ‘pathology’ is 
probably established and that reversal of the potential   adverse   perinatal   
outcomes   may   be   limited.   Many   health   professionals   advocate  
the    need    for  an   earlier   diagnostic/predictive  test   for  GDM, one 
among them is “THE FIRST TRIMESTER SERUM URIC ACID”. 
 
                  A pregnant woman with high risk factors as marked obesity, 
strong family history of Type II DM, previous history of GDM, impaired 
glucose metabolism or glucosuria, History of neonatal death, History of fetal 
macrosomia, along with > 4.2 mg/dl is at risk of developing GDM. 
 
                  The use of FIRST TRIMESTER SERUM URIC ACID as a 
predictor of GDM is simple, inexpensive, non invasive and easy to perform. 
This can be used as a screening test for the prediction of GDM.  
 
                    Hence in routine antenatal care with predictive test like first 
trimester serum uric acid can be applied as a screening test for all women 
then this dreadful Gestational diabetes can be treated in time. 
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PROFORMA 
ELEVATED FIRST TRIMESTER SERUM URIC ACID AS A 
PREDICTOR FOR DIAGNOSING GESTATIONAL DIABETES 
MELLITUS 
OUTCOME. 
NAME            :                                AGE:              I.P. NO.  : 
SOCIAL STATUS  :                           BOOKED/UNBOOKED: 
LMP   :                                              G    P    L    A 
EDD   :                                               GESTATIONAL AGE   : 
DATE OF USG   : 
OBSTETRIC HISTORY   : 
MATERNAL ILLNESS   : 
GENERAL EXAMINATION   : 
HT.                WT.                  PULSE:                BP:            TEMP: 
ANAEMIA:                           EDEMA:               CVS:           RS: 
OBETETRIC EXAMINATION 
P/A                : 
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USG                
           BLOOD INVESTIGATIONS‐ 
• SERUM URIC ACID(<14 weeks) 
• GCT (Glucose challenge test) ‐ 24‐ 28 weeks. 
• GTT (Glucose tolerance test). 
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